Protection of young children from influenza through universal vaccination

References

• Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18:64-76; PMID:8877331; http://dx.doi.org/10.1093/oxfordjournals.epirev.a017917
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Tsolia M, Finn A. Vaccination of healthy children against seasonal influenza: a European perspective. Pediatr Infect Dis J 2013; 32:881-888; PMID:23856713; http://dx.doi.org/10.1097/INF.0b013e3182918168
   PubMed Web of Science ®Google Scholar
• Committee On Infectious Diseases; American Academy Pediatrics. Recommendations for prevention and control of influenza in children, 2014-2015. Pediatrics 2014; 134:e1503-19. doi: 10.1542/peds.2014-2413
   Google Scholar
• Gill PJ, Ashdown HF, Wang K, Heneghan C, Roberts NW, Harnden A, Mallett S. Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis. Lancet Respir Med 2015; 3:139-149; PMID:25481379; http://dx.doi.org/10.1016/S2213-2600(14)70252-8
   PubMed Web of Science ®Google Scholar
• Esposito S, Marchisio P, Principi N. The global state of influenza in children. Pediatr Infect Dis J 2008; 27:S149-S153; PMID:18955890; http://dx.doi.org/10.1097/INF.0b013e31818a542b
   PubMedGoogle Scholar
• Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225-231; PMID:10648763; http://dx.doi.org/10.1056/NEJM200001273420401
   PubMed Web of Science ®Google Scholar
• Esposito S, Tagliabue C, Tagliaferri L, Semino M, Longo MR, Principi N. Preventing influenza in younger children. Clin Microbiol Infect 2012; 18(Suppl. Five):42-49 (2012); PMID:22862744; http://dx.doi.org/10.1111/j.1469-0691.2012.03942.x
   PubMed Web of Science ®Google Scholar
• Department of Health (DoH). The flu immunisation programme 2013/14 – extension to children. Letter 26 July 2013. London: DoH. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/225360/Children_s_flu_letter_2013.pdf. Accessed on December 17th, 2014.
   Google Scholar
• Pebody RG, Green HK, Andrews N, Zhao H, Boddington N, Bawa Z, Durnall H, Singh N, Sunderland A, Letley L, Ellis J, Elliot AJ, Donati M, Smith GE, de Lusignan S, Zambon M. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill 2014; 19:pii 20823; PMID:24925457
   PubMedGoogle Scholar
• Antonova EN, Rycroft CE, Ambrose CS, Heikkinen T, Principi N. Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health 2012; 12:968; PMID:23146107; http://dx.doi.org/10.1186/1471-2458-12-968
   PubMed Web of Science ®Google Scholar
• Brüggenjürgen B, Lorrot M, Sheppard FR, Rémy V. Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe? Hum Vaccin Immunother 2014; 10:2290-2294; PMID:25424934; http://dx.doi.org/10.4161/hv.29090
   PubMed Web of Science ®Google Scholar
• Newall AT, Dehollain JP, Creighton P, Beutels P, Wood JG. Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability. Pharmacoeconomics 2013; 31:693-702; PMID:23645539; http://dx.doi.org/10.1007/s40273-013-0060-7
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Adjuvanted influenza vaccines. Hum Vaccin Immunother 2012; 8:59-66; PMID:22252004; http://dx.doi.org/10.4161/hv.8.1.18011
   PubMed Web of Science ®Google Scholar
• Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, et al. Evaluation of adjuvanted pandemic H1N1 (2009). influenza vaccine after one and two doses in young children. Pediatr Infect Dis J 2011; 30:402-407; PMID:21178654; http://dx.doi.org/10.1097/INF.0b013e3182068f33
   PubMed Web of Science ®Google Scholar
• Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D. Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine 2011; 30:35-41; PMID:22063386; http://dx.doi.org/10.1016/j.vaccine.2011.10.062
   PubMed Web of Science ®Google Scholar
• Carmona A, Omeñaca F, Tejedor JC, Merino JM, Vaman T, Dieussaert I, Gillard P, Arístegui J. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months. Vaccine 2010; 28:5837-5844; PMID:20600478; http://dx.doi.org/10.1016/j.vaccine.2010.06.065
   PubMed Web of Science ®Google Scholar
• Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen SL, Hublin C, Julkunen I, Olsén P, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012; 7:e33536; PMID:22470453; http://dx.doi.org/10.1371/journal.pone.0033536
   PubMed Web of Science ®Google Scholar
• Barker CI, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis 2014; 14:227-238; PMID:24360892; http://dx.doi.org/10.1016/S1473-3099(13)70238-X
   PubMed Web of Science ®Google Scholar
• Podda A, Del Giudice G. MF-59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile. Expert Rev Vaccines 2003; 2:197-204; PMID:12899571; http://dx.doi.org/10.1586/14760584.2.2.197
   PubMedGoogle Scholar
• Garçon N, Chomez P, Van Mechelen M. GlaxoSmithKline Adjuvant System in vaccines: concepts, achievement and perspectives. Expert Rev Vaccines 2007; 6:723-729; http://dx.doi.org/10.1586/14760584.6.5.723
   PubMed Web of Science ®Google Scholar
• Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010; 33:492-503; PMID:21029960; http://dx.doi.org/10.1016/j.immuni.2010.10.002
   PubMed Web of Science ®Google Scholar
• Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine 2001; 19:2673-2680; PMID:11257408; http://dx.doi.org/10.1016/S0264-410X(00)00499-0
   PubMed Web of Science ®Google Scholar
• Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, Podda A. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J 2009; 28:563-571; PMID:19561422; http://dx.doi.org/10.1097/INF.0b013e31819d6394
   PubMed Web of Science ®Google Scholar
• Vesikari T, Groth N, Karvonen A, Borkowski A, Pellegrini M. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. Vaccine 2009; 27:6291-6295; PMID:19840662; http://dx.doi.org/10.1016/j.vaccine.2009.02.004
   PubMed Web of Science ®Google Scholar
• Nolan T, Bravo L, Ceballos A, Mitha E, Gray G, Quiambao B, Patel SS, Bizjajeva S, Bock H, Nazaire-Bermal N, et al. Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children. Vaccine 2014; 32:6146-6156; PMID:25223266; http://dx.doi.org/10.1016/j.vaccine.2014.08.068
   PubMed Web of Science ®Google Scholar
• Zedda L, Forleo-Neto E, Vertruyen A, Raes M, Marchant A, Jansen W, Clouting H, Arora A, Beatty ME, Galli G, et al. Dissecting the immune-response to MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines in children less than three years of age. Pediatr Infect Dis J 2014; 34(1):73-8; Epub Jul 16.
   Web of Science ®Google Scholar
• Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Della Cioppa G. Safety and immunogenicity of an MF59(®)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Vaccine 2015; 33:174-181; PMID:25444803; http://dx.doi.org/10.1016/j.vaccine.2014.10.085
   PubMed Web of Science ®Google Scholar
• Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Della Cioppa G. Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6–35 months of age. Pediatr Infect Dis J 2014; 33:e320-e329; PMID:24978857; http://dx.doi.org/10.1097/INF.0000000000000462
   PubMedGoogle Scholar
• Esposito S, Pugni L, Daleno C, Ronchi A, Valzano A, Serra D, Mosca F, Principi N. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Pediatrics 2011; 127:e1161-e1168; PMID:21464195; http://dx.doi.org/10.1542/peds.2010-1920
   PubMed Web of Science ®Google Scholar
• Mischler R, Metcalfe IC. Inflexal V a trivalent virosome subunit influenza vaccine: production. Vaccine 2002; 20 (Suppl. Five):B17-23; PMID:12477413; http://dx.doi.org/10.1016/S0264-410X(02)00512-1
   PubMedGoogle Scholar
• Huckriede A, Bungener I, Stegmann T, Daemen T, Medema J, Palache AM, Wilschut J. The virosomal concept for influenza vaccine. Vaccine 2005; 23:S26-S38; PMID:16026906; http://dx.doi.org/10.1016/j.vaccine.2005.04.026
   PubMed Web of Science ®Google Scholar
• Calcagnile S, Zuccotti GV. The virosomal adjuvanted influenza vaccine. Expert Opin Biol Ther 2010; 10:191-200; PMID:20088714; http://dx.doi.org/10.1517/14712590903431014
   PubMed Web of Science ®Google Scholar
• Kanra G, Marchisio P, Feiterna-Sperling C, Gaedicke G, Lazar H, Durrer P, Kürsteiner O, Herzog C, Kara A, Principi N. Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. Pediatr Infect Dis J 2004; 23:300-306; PMID:15071282; http://dx.doi.org/10.1097/00006454-200404000-00005
   PubMed Web of Science ®Google Scholar
• Esposito S, Marchisio P, Montinaro V, Bianchini S, Weverling GJ, Pariani E, Amendola A, Fabiano V, Pivetti V, Zanetti A, et al. The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to 36 months: data from a randomized, phase III study. Vaccine 2012; 30:7005-7012; PMID:23059357; http://dx.doi.org/10.1016/j.vaccine.2012.09.069
   PubMed Web of Science ®Google Scholar
• Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 1993; 92:2587-2596; PMID:8254016; http://dx.doi.org/10.1172/JCI116873
   PubMed Web of Science ®Google Scholar
• Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993; 151:6535-6545; PMID:7504023
   PubMed Web of Science ®Google Scholar
• Spellberg B. The cutaneous citadel: a holistic view of skin and immunity. Life Sci 2000; 67:477-502; PMID:10993114; http://dx.doi.org/10.1016/S0024-3205(00)00653-6
   PubMed Web of Science ®Google Scholar
• Halperin W, Weiss WI, Altman R, Diamond MA, Black KJ, Iaci AW, Black HC, Goldfield M. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature. Am J. Public Health 1979; 69:1247-1251; http://dx.doi.org/10.2105/AJPH.69.12.1247
   PubMed Web of Science ®Google Scholar
• Falsey AR. New emerging technologies and the intradermal route: the novel way to immunize against influenza. Vaccine 2010; 28S:D24-D32; http://dx.doi.org/10.1016/j.vaccine.2010.08.026
   Google Scholar
• Vankerckhoven V, Van Damme P. Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines. Expert Opin Drug Deliv 2010; 7:1109-1125; PMID:20716021; http://dx.doi.org/10.1517/17425247.2010.507668
   PubMed Web of Science ®Google Scholar
• Durando P, Iudici R, Alicino C, Alberti M, de Florentis D, Ansaldi F, Icardi G. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Hum Vaccin 2011; 7 (Suppl. One):29-40; http://dx.doi.org/10.4161/hv.7.0.14560
   PubMed Web of Science ®Google Scholar
• Esposito S, Daleno C, Picciolli I, Tagliaferri L, Scala A, Prunotto G, Montinaro V, Galeone C, Principi N. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine 2011; 29:7606-7610; PMID:21855592; http://dx.doi.org/10.1016/j.vaccine.2011.08.021
   PubMed Web of Science ®Google Scholar
• Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, et al. Half- vs full-dose trivalent influenza vaccine (2004–2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168:2405-2414; PMID:19064822; http://dx.doi.org/10.1001/archinternmed.2008.513
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Hottes TS, Chong M, De Serres G, Scheifele DW, Ward BJ, Halperin SA, Janjua NZ, Chan T, Sabaiduc S, et al. Randomized controlled trial of dose-response to influenza vaccine in children 6–23 months of age. Pediatrics 2011; 128:e276-e289; PMID:21768314; http://dx.doi.org/10.1542/peds.2010-2777
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999–2012. Clin Infect Dis 2014; 59:1519-1524; PMID:25139969; http://dx.doi.org/10.1093/cid/ciu664
   PubMed Web of Science ®Google Scholar
• Toback SL, Levin MJ, Block SL, Belshe RB, Ambrose CS, Falloon J. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine. Expert Rev Vaccines 2012; 11:1293-1303; PMID:23151111; http://dx.doi.org/10.1586/erv.12.108
   PubMed Web of Science ®Google Scholar
• Domachowske JB, Pankow-Culot H, Bautista M, Feng Y, Claeys C, Peeters M, Innis BL, Jain V. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis 2013; 207:1878-1887; PMID:23470848; http://dx.doi.org/10.1093/infdis/jit091
   PubMed Web of Science ®Google Scholar
• Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis 2013; 208:544-553; PMID:23847058; http://dx.doi.org/10.1093/infdis/jit263
   PubMed Web of Science ®Google Scholar
• Jain VK, Rivera L, Zaman K, Espos RA Jr, Sirivichayakul C, Quiambao BP, Rivera-Medina DM, Kerdpanich P, Ceyhan M, Dinleyici EC, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med 2013; 369:2481-2491; PMID:24328444; http://dx.doi.org/10.1056/NEJMoa1215817
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Luke C, Coelingh K. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Resp Vir 2008; 2:193-202; http://dx.doi.org/10.1111/j.1750-2659.2008.00056.x
   PubMed Web of Science ®Google Scholar
• Carter NJ, Curran MP. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults. Drugs 2011; 71:1591-1622; PMID:21861544; http://dx.doi.org/10.2165/11206860-000000000-00000
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Statistical Review and Evaluation – Flumist Quadrivalent. Available at: www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm294691.pdf - 20k. Accessed on December 17th, 2014.
   Google Scholar
• Tam JS, Capeding MRZ, Lum LCS, Chotpitayasunondh T, Jiang Z, Huang LM, Lee BW, Qian Y, Samakoses R, Lolekha S, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 2007; 26:619-628; PMID:17596805; http://dx.doi.org/10.1097/INF.0b013e31806166f8
   PubMed Web of Science ®Google Scholar
• Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD; D153-P504 LAIV Study Group. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J 2009; 28:365-371; PMID:19395948; http://dx.doi.org/10.1097/INF.0b013e31819219b8
   PubMed Web of Science ®Google Scholar
• Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000; 136:168-175; PMID:10657821; http://dx.doi.org/10.1016/S0022-3476(00)70097-7
   PubMed Web of Science ®Google Scholar
• Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338:1405-1412; PMID:9580647; http://dx.doi.org/10.1056/NEJM199805143382002
   PubMed Web of Science ®Google Scholar
• Forrest BD, Pride MW, Dunning AJ, Capeding MR, Chotpitayasunondh T, Tam JS, Rappaport R, Eldridge JH, Gruber WC. Correlation of cellular immune responses with protection against culture confirmed influenza virus in young children. Clin Vaccine Immunol 2008; 15:1042-1053; PMID:18448618; http://dx.doi.org/10.1128/CVI.00397-07
   PubMed Web of Science ®Google Scholar
• Esposito S, Montinaro V, Groppali E, Tenconi R, Semino M, Principi N. Live attenuated intranasal influenza vaccine. Hum Vaccin Immunother 2012; 8:76-80; PMID:22251995; http://dx.doi.org/10.4161/hv.8.1.18809
   PubMed Web of Science ®Google Scholar
• Tam JS, Capeding MRZ, Lum LCS, Chotpitayasunondh T, Jiang Z, Huang LM, Lee BW, Qian Y, Samakoses R, Lolekha S, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 2007; 26:619-628; PMID:17596805; http://dx.doi.org/10.1097/INF.0b013e31806166f8
   PubMed Web of Science ®Google Scholar
• Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD, et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006; 118:2298-2312; PMID:17142512; http://dx.doi.org/10.1542/peds.2006-0725
   PubMed Web of Science ®Google Scholar
• Belshe RB, Gruber WC. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J 2000; 19(5 Suppl. One):S66-S71; PMID:10821474; http://dx.doi.org/10.1097/00006454-200005001-00010
   PubMedGoogle Scholar
• Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-696; PMID:17301299; http://dx.doi.org/10.1056/NEJMoa065368
   PubMed Web of Science ®Google Scholar
• Bergen R, Black S, Shinefield H, Lewis E, Ray P, Hansen J, Walker R, Hessel C, Cordova J, Mendelman PM. Safety of cold adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004; 23:138-144; PMID:14872180; http://dx.doi.org/10.1097/01.inf.0000109392.96411.4f
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Flumist Available at: www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm094047.htm − 42 k - 2014-08-19. Accessed on December 17 th, 2014.
   Google Scholar
• Turner PJ, Southern J, Andrews NJ, Miller E, Erlewyn-Lajeunesse M; SNIFFLE Study Investigators. Safety of live attenuated influenza vaccine in atopic children with egg allergy. J Allergy Clin Immunol 2015; Epub Feb 1.
   Web of Science ®Google Scholar
• Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD; GRC28 Study Team. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Pediatr Infect Dis J 2010; 29:105-110; PMID:19934787; http://dx.doi.org/10.1097/INF.0b013e3181b84c34
   PubMed Web of Science ®Google Scholar
• Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004; 53 (RR 6):1-40; PMID:15163927
   PubMedGoogle Scholar
• Dabrera G, Zhao H, Andrews N, Begum F, Green H, Ellis J, Elias K, Donati M, Zambon M, Pebody R. Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14. Euro Surveill 2014; 19:20959; PMID:25411687
   PubMedGoogle Scholar
• Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, MacDonald N. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007; 176:463-468; PMID:17296958; http://dx.doi.org/10.1503/cmaj.061435
   PubMed Web of Science ®Google Scholar
• Schanzer DL, Langley JM, Tam TW. Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J Obstet Gynaecol Can 2007; 29:622-629; PMID:17714614
   PubMedGoogle Scholar
• Tuyishime JD, De Wals P, Moutquin JM, Frost E. Influenza-like illness during pregnancy: results from a study in the eastern townships. J Obstet Gynaecol Can 2003; 25:1020-1025; PMID:14663536
   PubMedGoogle Scholar
• Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:1094-1102; PMID:9850132; http://dx.doi.org/10.1093/oxfordjournals.aje.a009587
   PubMed Web of Science ®Google Scholar
• Omer SB, Goodman D, Steinhoff MC, Rochat R, Klugman KP, Stoll BJ. Maternal influenza immunization and reduced likehood of prematurity and small gestational age births: a retrospective cohort study. PLoS Med 2011; 8:e1000441; PMID:21655318; http://dx.doi.org/10.1371/journal.pmed.1000441
   PubMed Web of Science ®Google Scholar
• Sheffield J, Roberts S, Lorimer M, Casey B, Mcintire D, Wendel G. The efficacy and safety of influenza vaccination in pregnan cy. In Obstetrics Ajog, editor. Society for maternal-fetal medicine: 31st annual meetings: the pregnancy meeting, 2011; 66.
   Google Scholar
• Zaman K, Roy E, Arifeen SE. Effectiveness of maternal in fluenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-1564; PMID:18799552; http://dx.doi.org/10.1056/NEJMoa0708630
   PubMed Web of Science ®Google Scholar
• Thompson MG, Li DK, Shifflett P, Sokolow LZ, Ferber JR, Kurosky S, Bozeman S, Reynolds SB, Odouli R, Henninger ML, et al. Effective ness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-con trol study during the 2010–2011 and 2011–2012 influenza seasons. Clin Infect Dis 2014; 58:449-457; PMID:24280090; http://dx.doi.org/10.1093/cid/cit750
   PubMed Web of Science ®Google Scholar
• Mbawuike IN, Six HR, Cate TR, Couch RB. Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. J Virol 1990; 64:1370-1374; PMID:2304146
   PubMed Web of Science ®Google Scholar
• Sweet C, Jakeman KJ, Smith H. Role of milk-derived IgG in passive maternal protection of neonatal ferrets against influenza. J Gen Virol 1987; 68:2681-2686; PMID:3668509; http://dx.doi.org/10.1099/0022-1317-68-10-2681
   PubMed Web of Science ®Google Scholar
• Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993; 168:647-656; PMID:8354906; http://dx.doi.org/10.1093/infdis/168.3.647
   PubMed Web of Science ®Google Scholar
• Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010; 51:1355-1361; PMID:21058908; http://dx.doi.org/10.1086/657309
   PubMed Web of Science ®Google Scholar
• Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011; 204 (6 Suppl. One):S141-S148; PMID:21492825; http://dx.doi.org/10.1016/j.ajog.2011.02.042
   PubMed Web of Science ®Google Scholar
• Eick AA, Uyeki TM, Klimov A. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011; 165:104-111; PMID:20921345; http://dx.doi.org/10.1001/archpediatrics.2010.192
   PubMed Web of Science ®Google Scholar
• Puleston RL, Bugg G, Hoschler K, Konje J, Thornton J, Stephenson I, Myles P, Enstone J, Augustine G, Davis Y, et al. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy. Health Technol Assess 2010; 14:1-82; PMID:21208547; http://dx.doi.org/10.3310/hta14550-01
   PubMed Web of Science ®Google Scholar
• Zuccotti G, Pogliani L, Pariani E, Amendola A, Zanetti A. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAMA 2010; 304:2360-2361; PMID:21119083; http://dx.doi.org/10.1001/jama.2010.1729
   PubMed Web of Science ®Google Scholar
• Ding H, Black CL, Ball S, Donahue S, Izrael D, Williams WW, Kennedy ED, Bridges CB, Lu PJ, Kahn KE, et al. Influenza vaccination coverage among pregnant women–United States, 2013–14 influenza season. MMWR Morb Mortal Wkly Rep 2014; 63:816-821; PMID:25233283
   PubMed Web of Science ®Google Scholar